Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.48−0.04 (-2.63%)
Close on Nov 20, 2026Market cap $70.14MP/E –Yield –
Zhengye Biotechnology net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -CN¥69.78M, down 717.0% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CN¥69.78M | -717.0% |
| FY2024 | Dec 31, 2024 | CN¥11.31M | -64.0% |
| FY2023 | Dec 31, 2023 | CN¥31.46M | -32.7% |
| FY2022 | Dec 31, 2022 | CN¥46.74M | – |
See a number that looks wrong?